- AU$108.72m
- AU$100.34m
- AU$2.19m
Australia Stock Exchange release from NYRADA : NYX-PCSK9i with Statin Achieves 65% Cholesterol Reduction
Australia Stock Exchange release from NYRADA : PRE_NR Ends: 08:34:37
Australia Stock Exchange release from NYRADA : Results of Meeting
Australia Stock Exchange release from NYRADA : Notice of Extraordinary General Meeting/Proxy Form
Australia Stock Exchange release from NYRADA : Nyrada Receives A$1.0M R&D Tax Incentive Rebate
Australia Stock Exchange release from NYRADA : PRE_NR Ends: 08:35:57
Australia Stock Exchange release from NYRADA : NYR Announces New Potent Cholesterol-Lowering Candidates
Australia Stock Exchange release from NYRADA : PRE_NR Ends: 08:32:59
Australia Stock Exchange release from NYRADA : Nyrada Quarterly Activities Report & Appendix 4C
Australia Stock Exchange release from NYRADA : PRE_NR Ends: 10:20:33
Australia Stock Exchange release from NYRADA : Ceasing to be a substantial holder
Australia Stock Exchange release from NYRADA : Change in substantial holding
Australia Stock Exchange release from NYRADA : Cleansing Statement
Australia Stock Exchange release from NYRADA : Appendix 2A
Australia Stock Exchange release from NYRADA : Change in substantial holding
ASX-listed Nyrada falls most in nearly a month on discounted placement
Brief: Nyrada Receives Firm Commitments To Raise A$11 Million
Australia Stock Exchange release from NYRADA : Proposed issue of Securities - NYR
Australia Stock Exchange release from NYRADA : Nyrada Receives Firm Commitments to Raise A$11 Million